RSVP now to secure your spot for tomorrow's free ATMP webinar (9am EST / 2pm GMT/ 3pm CET)!

Join us as Dr. James Fang, Head of the RNA Center of Excellence at Innoforce, dives into the critical quality attributes for plasmid DNA, RNA, and LNP. He'll also share valuable insights on conquering CMC challenges in mRNA therapeutic development, including effective control strategies for managing process impurities.

Key takeaways from this webinar:

1. Overview the progress of mRNA technology development. What’s the key differences between mRNA vaccines and therapeutics development.

2. Discussing the key quality attributes for plasmid DNA, RNA and LNP.

3. Overcoming CMC challenges to make mRNA therapeutics effective, safe, and stable.

4. Implementing proper analytical control strategy for the control of process impurities

5. Innoforce RNA platform provides one-stop CDMO service that accelerates mRNA therapeutics and vaccines from preclinical stage, clinical to commercialization